- Pfizer's Effexor XR® and Greenstone Brands (venlafaxine HCL 150 mg extended-release capsules) because of a foreign tablet in one bottle
- Pain Free By Nature (reumofan plus tablets) for containing undeclared methocarbamol and diclofenac
- Shire Pharmaceuticals VPRIV® for injection for presence of visible particulate matter, identified as stainless steel and barium sulfate
- Pleo Homeopathic Drug Products for penicillin contamination
- Super Fat Burner, Maxi Gold, and Esmeralda dietary supplement for being an unapproved new drug
- Bella Vi dietary supplement for undeclared sibutramine and phenolphthalein
- Alli Weight Loss Product because of concerns about authenticity of product
- African Black Ant, XZen Gold, Xzone and other dietary supplements for being unapproved new drugs
- Thinogenics weight loss capsules for undeclared sibutramine
- Hospira propofol injectable emulsion, USP, for visible particulates
- CUBICIN daptomycin for injection because of the presence of particulate matter
- Hospira 1% lidocaine HCL injection, USP, because of the presence of visible particulates
- Hospira 0.25% Marcaine(™), 10 mL, single-dose vial - preservative free, for discolored solution with visible particles embedded in the glass
- Nano Well-being Health dietary supplement - Super Arthgold, for being an unapproved new drug.
Medical Devices
- Playtex AC/DC power adapters used with breast pump for potential for electric shock
- Greatbatch, Inc. Standard Offset Cup Impactors because Instructions for Use did not meet requirements for sterility assurance
- HeartMate II LVAS Pocket System Controller because of difficulties in changing from a primary system controller to a back-up controller